Select for export Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/npp.2011.228 PubMed 21956447 Copy citation Copy BibTeX Neuropsychopharmacology 2011-09-27 Quednow BB, Kometer M, Geyer MA, Vollenweider FX. Europe PMC Published psilocybinpsilocin Receptor PharmacologyConsciousnessObservational Study Clinical Trial More
Select for export P.1.e.017 The functional brain correlates of the psychedelic state: an arterial spin labelling study with psilocybin No abstract availability was recorded for this entry. Details DOI 10.1016/s0924-977x(11)70495-3 Copy citation Copy BibTeX European Neuropsychopharmacology 2011-08-06 Robin Carhart-Harris, David Erritzøe, James Stone, Rjs Wise, David Nutt OpenAlex Published psilocybin Mechanism of ActionCancer Patients Other More
Select for export Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-011-2358-5 PubMed 21674151 Copy citation Copy BibTeX Psychopharmacology 2011-06-14 Griffiths RR, Johnson MW, Richards WA, Richards BD, McCann U, Jesse R. Europe PMC Published psilocybin AnxietySpiritualityMystical Experience Clinical Trial More
Select for export Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881110388326 PubMed 21148021 Copy citation Copy BibTeX Journal of Psychopharmacology 2010-12-07 Halberstadt AL, Koedood L, Powell SB, Geyer MA. Europe PMC Published psilocybinpsilocin Receptor PharmacologyAnimal Study Animal Study More
Select for export Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881110382466 PubMed 20855349 Copy citation Copy BibTeX Journal of Psychopharmacology 2010-09-19 Studerus E, Kometer M, Hasler F, Vollenweider FX. Europe PMC Published psilocybin AnxietyObservational StudySafety Observational Study More
Select for export The administration of psilocybin to healthy, hallucinogen-experienced volunteers in a mock-functional magnetic resonance imaging environment: a preliminary investigation of tolerability. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881110367445 PubMed 20395317 Copy citation Copy BibTeX Journal of Psychopharmacology 2010-04-14 Carhart-Harris RL, Williams TM, Sessa B, Tyacke RJ, Rich AS, Feilding A Europe PMC Published psilocybin Brain ImagingAgingSafety Other More
Select for export Hallucinogens as discriminative stimuli in animals: LSD, phenethylamines, and tryptamines No abstract availability was recorded for this entry. Details DOI 10.1007/s00213-008-1356-8 PubMed 18979087 Copy citation Copy BibTeX Psychopharmacology 2008-10-30 J.C. Winter OpenAlex Published psilocybin PharmacologyReceptor PharmacologyToxicity Other More
Select for export Dopamine D4 receptor involvement in the discriminative stimulus effects in rats of LSD, but not the phenethylamine hallucinogen DOI No abstract availability was recorded for this entry. Details DOI 10.1007/s00213-008-1238-0 PubMed 18604600 Copy citation Copy BibTeX Psychopharmacology 2008-07-04 Danuta Marona-Lewicka, Benjamin R. Chemel, David E. Nichols OpenAlex Published psilocybin PharmacologyReceptor Pharmacology Other More
Select for export Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881108094300 PubMed 18593735 Copy citation Copy BibTeX Journal of Psychopharmacology 2008-06-30 Griffiths R, Richards W, Johnson M, McCann U, Jesse R. Europe PMC Published psilocybin WellbeingPersonality ChangeSpirituality Observational Study More
Select for export II. The Effects of Some Hallucinogens on Aggressiveness of Mice and Rats Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1159/000136297 PubMed 4672886 Copy citation Copy BibTeX Pharmacology 2008-05-27 Wojciech Kostowski, W Rewerski, T Piechocki OpenAlex Published psilocybin PharmacologyReceptor PharmacologyAnimal Study Animal Study More
Select for export Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-008-1129-4 PubMed 18488201 Copy citation Copy BibTeX Psychopharmacology 2008-05-17 Heekeren K, Daumann J, Neukirch A, Stock C, Kawohl W, Norra C Europe PMC Published psilocybin Receptor Pharmacology Clinical Trial More
Select for export Between prohibitions: patterns and meanings of magic mushroom use in the UK. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/10826080701772363 PubMed 18189205 Copy citation Copy BibTeX Substance use & misuse 2007-12-31 Riley SC, Blackman G PubMed Published psilocybin AnxietyObservational Study Observational Study More
Select for export Psilocybin links binocular rivalry switch rate to attention and subjective arousal levels in humans. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-007-0930-9 PubMed 17874073 Copy citation Copy BibTeX Psychopharmacology 2007-09-13 Carter OL, Hasler F, Pettigrew JD, Wallis GM, Liu GB, Vollenweider FX. Europe PMC Published psilocybin Receptor Pharmacology Other More
Select for export Psilocybin-induced stimulus control in the rat. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.pbb.2007.06.003 PubMed 17688928 Copy citation Copy BibTeX Pharmacology Biochemistry and Behavior 2007-06-21 Winter JC, Rice KC, Amorosi DJ, Rabin RA. Europe PMC Published psilocybinpsilocin Receptor PharmacologyAnimal Study Animal Study More
Select for export Prepulse inhibition of the startle reflex and its attentional modulation in the human S-ketamine and N,N-dimethyltryptamine (DMT) models of psychosis. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881107077734 PubMed 17591658 Copy citation Copy BibTeX Journal of Psychopharmacology 2007-04-30 Heekeren K, Neukirch A, Daumann J, Stoll M, Obradovic M, Kovar KA Europe PMC Published psilocybin Healthy Volunteers Other More
Select for export The effects of the preferential 5-HT2A agonist psilocybin on prepulse inhibition of startle in healthy human volunteers depend on interstimulus interval. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/sj.npp.1301324 PubMed 17299516 Copy citation Copy BibTeX Neuropsychopharmacology 2007-02-13 Vollenweider FX, Csomor PA, Knappe B, Geyer MA, Quednow BB. Europe PMC Published psilocybin Receptor PharmacologyConsciousnessAnimal Study Clinical Trial More
Select for export Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-006-0457-5 PubMed 16826400 Copy citation Copy BibTeX Psychopharmacology 2006-07-06 Griffiths RR, Richards WA, McCann U, Jesse R. Europe PMC Published psilocybin AnxietySpiritualityMystical Experience Observational Study More
Select for export Commentary on: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance by Griffiths et al. No abstract availability was recorded for this entry. Details DOI 10.1007/s00213-006-0461-9 Copy citation Copy BibTeX Psychopharmacology 2006-07-05 Herbert D. Kleber OpenAlex Published psilocybin SpiritualityMystical Experience Other More
Select for export Commentary on: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance by Griffiths et al. No abstract availability was recorded for this entry. Details DOI 10.1007/s00213-006-0460-x Copy citation Copy BibTeX Psychopharmacology 2006-07-05 Charles R. Schuster OpenAlex Published psilocybin SpiritualityMystical Experience Other More
Select for export Commentary on: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance by Griffiths et al. No abstract availability was recorded for this entry. Details DOI 10.1007/s00213-006-0458-4 Copy citation Copy BibTeX Psychopharmacology 2006-07-05 David E. Nichols OpenAlex Published psilocybin SpiritualityMystical Experience Other More
